GlaxoSmithKline S.A.E. (BIOC) Net Income
Net Income
EGP 34.03M
Fiscal year 2018
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2018 | 34.03M | -66.75% | 2.1% |
| 2017 | 102.34M | 2,703.66% | 7.04% |
| 2016 | -3.93M | -105.69% | -0.34% |
| 2015 | 69.11M | 7.85% | 6.84% |
| 2014 | 64.08M | -16.52% | 6.03% |
| 2013 | 76.76M | 6.44% | 7.37% |
| 2012 | 72.12M | -15.25% | 7.86% |
| 2011 | 85.1M | -8.54% | 9.83% |
| 2010 | 93.04M | 222.08% | 12.8% |
| 2009 | 28.89M | -65.5% | 4.33% |
| 2008 | 83.72M | -6.56% | 13.06% |
| 2007 | 89.6M | 40.72% | 15.35% |
| 2006 | 63.67M | — | 10.8% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.